For research use only. Not for therapeutic Use.
Cyamemazine(CAT: R012536) is a phenothiazine-class antipsychotic with potent serotonin 5-HT2 receptor antagonism and moderate dopamine D2 receptor blocking activity. Clinically used in parts of Europe for the treatment of schizophrenia, anxiety, and other psychotic disorders, it is distinguished from typical phenothiazines by its stronger serotonergic profile, which contributes to improved tolerability and reduced risk of extrapyramidal side effects. Cyamemazine also exhibits anxiolytic and sedative properties, making it useful in managing agitation and behavioral disturbances. As a pharmacological tool, it is valuable for research into neuropsychiatric disorders, serotonin-dopamine interactions, and therapeutic strategies in CNS pharmacology.
| CAS Number | 3546-03-0 |
| Synonyms | 10-[3-(dimethylamino)-2-methylpropyl]phenothiazine-2-carbonitrile |
| Molecular Formula | C19H21N3S |
| Purity | ≥95% |
| IUPAC Name | 10-[3-(dimethylamino)-2-methylpropyl]phenothiazine-2-carbonitrile |
| InChI | InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 |
| InChIKey | SLFGIOIONGJGRT-UHFFFAOYSA-N |
| SMILES | CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)C#N)CN(C)C |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
